FindTrial
Sign In

cap-aspirration lumpectomy (CASL) resection of fundic small submucosal tumors originating from the muscularis propria

cap-aspirration lumpectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-14004791
Enrollment
Unknown
Registered
2014-06-10
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small submucosal tumors at the muscularis propia of the gastric fundus

Interventions

operation:CASL

Sponsors

Department of Gastroenterology, Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with SMTs only located at muscularis propiawith small fundal SMTs(diameter =10mm); aged 18 to 65 years

Exclusion criteria

Exclusion criteria: SMTs are more than 10 mm; patients who were pregnant, those who did not provide informed consent, those considered unsuitable for general anesthesia and those with coagulopathy or with anticoagulant medications.

Design outcomes

Primary

MeasureTime frame
total operation time;Enucleation time;defect closure time;Pathology;—

Secondary

MeasureTime frame
operational expenses;safe resumption of diet;postoperative hospital stay;—

Countries

China

Contacts

Public ContactFachao Zhi

Department of Gastroenterology, Nanfang Hospital, Southern Medical University

zhifc41532@163.com+86 13076877351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026